Advertisement

Topics

AbbVie raises hopes for blood cancer patients

06:19 EDT 13 Jul 2018 | pharmaphorum

AbbVie has filed its Venclexta (venetoclax) for a new use that it hopes could change the treatment of one of the most aggressive cancers – acute myeloid leukaemia (AML). Developed in partnership with Roche, Venclexta is already approved in the US ...

Original Article: AbbVie raises hopes for blood cancer patients

NEXT ARTICLE

More From BioPortfolio on "AbbVie raises hopes for blood cancer patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...